Advancing usability of an influenza hemagglutinin virus-like particle vaccine expressing a chimeric cytokine
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Advancing usability of an influenza hemagglutinin virus-like particle vaccine expressing a chimeric cytokine ; volume:20 ; number:1 ; day:26 ; month:5 ; year:2023 ; pages:1-8 ; date:12.2023
Virology journal ; 20, Heft 1 (26.5.2023), 1-8, 12.2023
- Urheber
-
Imagawa, Toshifumi
Arasaki, Youta
Maegawa, Kenichi
Sugita, Shigeo
Nerome, Kuniaki
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12985-023-02076-1
- URN
-
urn:nbn:de:101:1-2023091108230164086590
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Imagawa, Toshifumi
- Arasaki, Youta
- Maegawa, Kenichi
- Sugita, Shigeo
- Nerome, Kuniaki
- SpringerLink (Online service)
Ähnliche Objekte (12)
Purification of a chimeric virus-like particle from a complex culture medium
Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness
Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunity
Plant-derived virus-like particle vaccines drive cross-presentation of influenza A hemagglutinin peptides by human monocyte-derived macrophages
Design of hepadnavirus core protein-based chimeric virus-like particles carrying epitopes from respiratory syncytial virus
A chimeric MERS-CoV virus-like particle vaccine protects mice against MERS-CoV challenge
Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates
Identification and selective expansion of functionally superior T cells expressing chimeric antigen receptors
Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
Hepatitis E Virus Capsid as a Carrier of Exogenous Antigens for the Development of Chimeric Virus-Like Particles
Hemagglutinin virus-like particles incorporated with membrane-bound cytokine adjuvants provide protection against homologous and heterologous influenza virus challenge in aged mice
T cells expressing NKG2D chimeric antigen receptors efficiently eliminate glioblastoma and cancer stem cells
Purification of a chimeric virus-like particle from a complex culture medium
Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness
Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunity
Plant-derived virus-like particle vaccines drive cross-presentation of influenza A hemagglutinin peptides by human monocyte-derived macrophages
Design of hepadnavirus core protein-based chimeric virus-like particles carrying epitopes from respiratory syncytial virus
A chimeric MERS-CoV virus-like particle vaccine protects mice against MERS-CoV challenge
Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates
Identification and selective expansion of functionally superior T cells expressing chimeric antigen receptors
Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
Hepatitis E Virus Capsid as a Carrier of Exogenous Antigens for the Development of Chimeric Virus-Like Particles
Hemagglutinin virus-like particles incorporated with membrane-bound cytokine adjuvants provide protection against homologous and heterologous influenza virus challenge in aged mice
T cells expressing NKG2D chimeric antigen receptors efficiently eliminate glioblastoma and cancer stem cells
Purification of a chimeric virus-like particle from a complex culture medium
Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness
Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunity
Plant-derived virus-like particle vaccines drive cross-presentation of influenza A hemagglutinin peptides by human monocyte-derived macrophages
Design of hepadnavirus core protein-based chimeric virus-like particles carrying epitopes from respiratory syncytial virus
A chimeric MERS-CoV virus-like particle vaccine protects mice against MERS-CoV challenge
Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates
Identification and selective expansion of functionally superior T cells expressing chimeric antigen receptors
Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
Hepatitis E Virus Capsid as a Carrier of Exogenous Antigens for the Development of Chimeric Virus-Like Particles
Hemagglutinin virus-like particles incorporated with membrane-bound cytokine adjuvants provide protection against homologous and heterologous influenza virus challenge in aged mice